The new facility offers an expanded laboratory alongside meeting areas dedicated to development meetings, formulation workshops, and brainstorming sessions
New site expands manufacturing footprint to meet future demand; ensures continued on-time delivery rate of >99.9% to patients across western US, Alaska and Hawaii
Facility also named 2025 ISPE Facility of the Year Winner for Social Impact - Unmet Medical Needs
Aim is to predict novel catalysts using machine learning (ML) and artificial intelligence (AI) techniques
The San Francisco facility is part of Thermo Fisher’s global pharma services network of more than 15 locations supporting cell and gene therapies.
The strategic acquirer maintains a nationwide presence in the LTC pharmacy space
The 41,000 sq ft facility will be utilized to manufacture clinical to commercial-grade peptide products for increased manufacturing capacity
The latest addition, a new API facility in Morrisville, North Carolina, will produce key components for solid dosage tablets, capsules, and RNA therapeutics
The company says the product will now be distributed exclusively through Anovo Specialty Pharmacy
The company doses first patient in US study of Deraphan, as Dolby Ventures joins €53M Series B to support neuropsychiatric innovation
Subscribe To Our Newsletter & Stay Updated
